As we progress in our accelerator mentorship with Blue Cross Blue Shield of Illinois, we continue to uncover the true power of Compris. Lost lives and co-morbid illnesses caused from substance misuse continue to inflict untold pain with no real resolution. Until now.
Compris is not just a comprehensive addiction assessment. Our completely automated, transformative tool is an addiction risk predictor with targeted prevention, detailed person-specific care plan, and interval resilience measurement to track client's progress, as well as treatment program effectiveness. (Please click here to learn more.)
What do we mean exactly?
Compris' Risk BUILD© model captures Lifetime Addiction Risk (Blueprint: genetics/epigenetics, User traits, Injured developing brain, Life stressors, and Damage from use), including substance-specific risk based on personality traits (sensation seeking, anxiety, negative thinking, or impulsive behavior).
Each of Compris' care plans come with a specific list of current resources and those in need of improvement. Abundant resilience resources have long been established as paramount to healthy living (Positive Psychology).
Compris' Current Adjusted Risk is derived from the client's Lifetime Risk and Current Resilience. Both resilience and risk help determine likelihood of sustained remissions.
Risk and resilience also come into play in determining the level of care placement. Perhaps someone with good resilience, especially safety in the home, would do better if they lived in their current environment during treatment, even if their acuity level is more severe. Plus, Compris guides medication selection by determining which clients will likely manage substance detox.
And it doesn't stop there. Let's talk about quantified progress assessments. Compris adds measurable quality to programs. Providers are encouraged to perform Compris' interval resilience assessment to track client's progress and make changes to their treatment regime as indicated in the results.
The truth is, Substance Use Disorders (SUD) are chronic illnesses that are being assessed and treated with episodic care. Because of this, it takes 17 years, on average, to achieve the 50% 1-year remission rates other chronic illnesses reach in the first year. Why haven't we set a precedent for addiction prevention in the way we have for other potential illnesses, such as encouraging colonoscopies, EKGs, or mammograms? Isn't it time to create addiction parity with other chronic illnesses?
So, folks, Compris is not just your run of the mill addiction screen, that looks primarily at the last 30 days and level of care placement without specific recommendations. (In 2019, the US Prevention Services Task Force established that current screens don't cut the mustard for lifetime illness management.) Compris is a lifetime prevention and addiction management tool, guide to treatment and level of care placement, all based on risk, resilience, and illness acuity and severity. It's a data-driven path to illness and population health equity for those with substance addictions. It offers providers quantifiable prevention, treatment, and ongoing wellness guidance, supports increased tele-health and alternative treatment access, and creates an unprecedented research and practice-informing database with machine learning to accelerate our knowledge of how best to treat and manage this devastating chronic illness.
Compris is accessible to anyone with internet access or a smart phone, takes 5-minutes to administer, 15-30 minutes for clients to complete, and delivers results to providers immediately upon completion. This is especially important with the pandemic and increased need for addiction and telehealth alternatives.
Please pass on this information to those who might be interested in confirming Compris' value in their efforts to support this population. To learn more about how to manage this devastating disease, please visit compriscare.com or sign up here.
Thank you for your ongoing support.
Stay safe and healthy.
Joyce Ann and Calvin McGinn